Health Biotech Limited WHO-GMP
Health Biotech Limited
Health Biotech LimitedHealth Biotech Limited  
Health Biotech Limited Health Biotech Limited



cardiovascular-injections
Health Biotech Limited
Home - Biological Injections - Urokinase Injection

Urokinase Injection

It is obtained from culture of human kidney cells. It is not antigenic in nature.

Composition : 250000IU, 500000IU, 75OOOOOIU
Indications : Acute myocardial infarction, acute thrombosis of arteries, pulmonary embolism and deep vein thrombosis.
Contraindications : Any surgical procedure with in last 10 days, recent trauma, peptic ulcer, pregnancy, severe uncontrolled hypertension, bleeding disorders.
Safety Profile : Lactation, cerebrovascular diseases, atrial fibrillation.
Adverse Effects : Haemorrhage, vomiting.
Drug Interactions : Aspirin, dipyridamole, heparin and oral anticoagulants increase the risk of haemorrhage.
Dosage : Acute myocardial infarction 10000 I.U./kg intravenously or 2000000 I.U. as bolus intravenous infusion over 1 hour or 10000 I.U per min. by intracoronary route. Clot is usually lysed within 30 mts. of intravenous route administration or 1 hour of intracoronary admn.
Purity :Not less than 99%.
» Request a quote

Urokinase
Health Biotech Limited
Our Products
Oncology (Anti Cancer Injectables)  |  Pre-Filled Syringes  |  Antibiotics & Anti-Infectives  |  New Molecules (FDC)  |  Liquid Ampoules / Vials  |  Biological Injections
Cardiovascular Injections  |  Neurology  |  Other Injectables  |  Hormones  |  Eye/ Ear/ Nasal Drops  |  Liquid Syrups , Dry Syrups & Redi-Mix Syrups  |  Ointments/Creams


Clicky Web Analytics